Intronix Technologies Upgrades

Former OBIO CAAP company, Intronix Technologies, have upgraded their Myoguide Stimulator capability.

The Myoguide is a handheld injection guidance device that uses muscle signals (EMG) and stimulation, to help clinicians target the optimal site for injection of therapeutic Botox® type drugs, used for the management of muscle spasms associated with pain and spasticity.

Clinicians can now stimulate in both 1.0mA and 0.1mA steps over the full 0-20mA stimulation range.

The new 0.1mA step stimulation capability is especially relevant for nerve location, chemodenervation, in addition to ultrasound guidance procedures.

Click Here to Learn More

Previous
Previous

The ChipCare Team Grows

Next
Next

Eve Medical Featured in MIT Technology Review